Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
2024 Global Cancer Biomarkers Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
2024 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Industry (2030 Outlook)
... (Wharry Sharpe Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market ... Read More
-
2024 Global Cancer Diagnostics Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
Thymus Cancer - Pipeline Insight, 2024
... picture of the Thymus Cancer pipeline landscape is provided, which includes the disease overview and Thymus Cancer treatment guidelines. The assessment part of the report embraces in-depth Thymus Cancer commercial assessment and clinical assessment of ... Read More
-
Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2024
... the Undifferentiated Pleomorphic Sarcoma (UPS) market. A detailed picture of the Undifferentiated Pleomorphic Sarcoma (UPS) pipeline landscape is provided, which includes the disease overview and Undifferentiated Pleomorphic Sarcoma (UPS) treatment guidelines. The assessment part of ... Read More
-
Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024
... the Acute Myelogenous Leukemia (AML) market. A detailed picture of the Acute Myelogenous Leukemia (AML) pipeline landscape is provided, which includes the disease overview and Acute Myelogenous Leukemia (AML) treatment guidelines. The assessment part of ... Read More
-
Advanced Cancer Pain Management (ACPM) - Pipeline Insight, 2024
... growth prospects across the Advanced Cancer Pain Management (ACPM) market. A detailed picture of the Advanced Cancer Pain Management (ACPM) pipeline landscape is provided, which includes the disease overview and Advanced Cancer Pain Management (ACPM) ... Read More
-
Anaplastic Thyroid Cancer - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Chronic lymphocytic leukemia- Pipeline Insight, 2024
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Chronic Myeloid Leukemia - Pipeline Insight, 2024
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Cancer Biomarkers Market
... (Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Thyroid Cancer, Bladder Cancer, Melanoma, Non-Hodgkins Lymphoma, Endometrial Cancer, Kidney Cancer and Leukemia) and Key Geographical Regions (North America, Europe and Asia-Pacific) The cancer biomarkers market is ... Read More
-
MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and Region Analysis - Analysis and Forecast, 2023-2033
... detect and quantify the small number of cancer cells that remain in a patient's body after treatment. It involves sensitive technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and flow cytometry to identify ... Read More
-
Global Prostate Cancer Nuclear Medicine Diagnostics Market Growth (Status and Outlook) 2024-2030
... in 2023. With growing demand in downstream market, the Prostate Cancer Nuclear Medicine Diagnostics is forecast to a readjusted size of US$ 1462 million by 2030 with a CAGR of 11.0% during review period. The ... Read More
-
Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033
... Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Musculoskeletal Disorders Drugs; Metabolic Disorders Drugs4) By End-User: Biotech And Pharma Companies; Research InstitutionsCovering: BASF SE; Evonik Industries AG; Pfizer Inc.; Arkema Inc.; Koninklijke DSM N.V. Pharmaceutical Intermediates Global ... Read More
-
Global Chronic Lymphocytic Leukemia Therapeutics Market 2024-2028
... the chronic lymphocytic leukemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
2024 Global: Cancer Gene Therapy Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 Global: Breast Cancer Therapeutics - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
2024 Global: Cancer Biomarkers Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
2024 Global: Cancer Registry Software Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
Monoclonal Antibody (mABs) Therapeutics Market by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
... projected to reach USD 497.5 billion by 2029 from an estimated USD 252.6 billion in 2024, at a CAGR of 14.5% during the forecast period. The driving factors of the monoclonal antibody therapeutics market include ... Read More
-
2024 Global: Cancer Monocolonal Antibodies - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
2024 Global: Breast Cancer Liquid Biopsy Market - Innovative Markets Forecast (2030) report
... data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 ... Read More
-
2024 Global: Cancer/Tumor Profiling Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
2024 Global: Cancer Supportive Care Drugs - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
2024 Global: Cancer Immunotherapy - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
Research Assistance
